PCRX
Pacira BioSciences, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-inputs (vergelijkbare managers):
breedte van houders +5.6% ·
aandelenstroom -4.8% ·
netto nieuwe posities +5.3%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 87 | +2 | 30.81M | $780.79M | +7 | −6 |
| Q1 2026 | 89 | -5 | 30.76M | $694.94M | +2 | −7 |
| Q4 2025 | 94 | -1 | 36.25M | $938.05M | — | −1 |
| Q3 2025 | 19 | +1 | 24.74M | $637.46M | +2 | −1 |
| Q2 2025 | 15 | 0 | 22.66M | $541.65M | +1 | −1 |
| Q1 2025 | 12 | -3 | 10.29M | $255.59M | — | −3 |
| Q4 2024 | 15 | +1 | 11.71M | $220.69M | +1 | — |
| Q3 2024 | 13 | 0 | 9.23M | $138.98M | +1 | −1 |
| Q2 2024 | 13 | — | 6.89M | $197.00M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 7.34M | -5.9% | $189.05M | 0.0% | ▼ Trim | 2 | SEC ↗ ×17 |
| 2 | The Vanguard Group ✦ (passief) | 5.20M | -3.9% | $133.94M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | Renaissance Technologies ✦ | 2.14M | -10.7% | $55.10M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 1.94M | -13.8% | $50.05M | 0.0% | ▼ Trim | 6 | SEC ↗ ×3 |
| 5 | State Street Global Advisors ✦ (passief) | 1.90M | -2.6% | $48.98M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Goldman Sachs Group ✦ | 1.31M | — | $33.76M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Geode Capital Management ✦ (passief) | 1.22M | +6.4% | $31.34M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Morgan Stanley ✦ | 1.14M | — | $29.45M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 9 | JPMorgan Chase ✦ | 872.40K | — | $22.48M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 10 | Wellington Management ✦ | 528.51K | -3.1% | $13.62M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 11 | Adage Capital Partners ✦ | 410.00K | Nieuw | $10.57M | 0.0% | New | 1 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 232.99K | +118.1% | $6.00M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 140.40K | -1.2% | $3.62M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 14 | Fidelity (FMR) ✦ | 101.82K | +9.9% | $2.62M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 15 | Citadel Advisors ✦ | 71.18K | Nieuw | $1.83M | 0.0% | New | 1 | SEC ↗ |
| 16 | Millennium Management ✦ | 70.76K | -86.3% | $1.82M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 49.98K | +4.3% | $1.29M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Arrowstreet Capital ✦ | 41.79K | +17.4% | $1.08M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 33.33K | -20.9% | $858,991 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Adage Capital Partners | $10.57M | 0.0% |
| Citadel Advisors | $1.83M | 0.0% |
Verlaten
| Marshall Wace | $4.55M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 3 houders, 13.02M aandelen, $12.57M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 6.00K aand · $217,920
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie